OSE Immunotherapeutics Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	107	115	157	81	123	188
Market Cap Growth	-24.13%	-26.38%	94.71%	-34.73%	-34.26%	45.49%
Enterprise Value	114	102	125	109	128	184
Last Close Price	4.75	5.15	7.17	4.28	6.67	10.28
PE Ratio	-	-	4.19	-	-	-
Forward PE	-	9.72	2.83	-	-	-
PS Ratio	59.79	64.80	1.88	36.17	6.74	7.14
PB Ratio	3.18	3.45	2.46	3.51	3.78	3.92
P/TBV Ratio	-	-	2.46	3.53	3.80	3.93
P/FCF Ratio	-	-	3.24	-	-	-
P/OCF Ratio	-	-	3.24	-	-	-
EV/Sales Ratio	64.20	57.51	1.50	49.07	6.99	7.01
EV/EBITDA Ratio	-	-	2.84	-	-	-
EV/EBIT Ratio	-	-	2.86	-	-	-
EV/FCF Ratio	-4.23	-	2.58	-	-	-
Debt / Equity Ratio	1.06	1.06	0.72	1.99	1.37	0.78
Debt / EBITDA Ratio	-	-	1.03	-	-	-
Debt / FCF Ratio	-	-	0.95	-	-	-
Asset Turnover	0.02	0.02	0.81	0.03	0.19	0.27
Quick Ratio	1.19	1.19	3.29	1.40	1.97	2.36
Current Ratio	1.54	1.54	3.46	1.62	2.29	2.64
Return on Equity (ROE)	-66.82%	-66.82%	86.29%	-82.69%	-44.10%	-30.85%
Return on Assets (ROA)	-18.42%	-18.42%	26.54%	-16.53%	-11.93%	-10.45%
Return on Invested Capital (ROIC)	-66.55%	-66.55%	81.47%	-45.10%	-35.78%	-32.30%
Return on Capital Employed (ROCE)	-50.40%	-50.40%	42.20%	-36.30%	-24.50%	-19.50%
Earnings Yield	-30.52%	-28.16%	23.88%	-28.56%	-14.39%	-8.98%
FCF Yield	-25.39%	-23.43%	30.84%	-24.56%	-15.01%	-5.54%
Buyback Yield / Dilution	-3.76%	14.22%	-31.11%	-5.58%	-2.05%	-16.71%

Updated Dec 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.